MH
CVS icon

Mark Hillman’s CVS Health CVS Stock Holding History

Mark Hillman’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.74M Sell
55,475
-11,987
-18% -$1.07M 4.15% 1
2026
Q1 		$4.85M Sell
67,462
-4,223
-6% -$325K 3.36% 8
2025
Q4 		$5.69M Sell
71,685
-10,674
-13% -$841K 3.58% 4
2025
Q3 		$6.21M Sell
82,359
-10,638
-11% -$729K 3.61% 4
2025
Q2 		$6.41M Sell
92,997
-7,453
-7% -$489K 3.5% 7
2025
Q1 		$6.81M Sell
100,450
-19,186
-16% -$1.15M 3.35% 3
2024
Q4 		$5.37M Sell
119,636
-1,891
-2% -$106K 1.99% 31
2024
Q3 		$7.64M Sell
121,527
-2,802
-2% -$163K 2.62% 17
2024
Q2 		$7.34M Buy
124,329
+10,291
+9% +$644K 2.59% 18
2024
Q1 		$9.1M Buy
114,038
+376
+0.3% +$28.7K 2.92% 11
2023
Q4 		$8.97M Buy
113,662
+1,354
+1% +$96.4K 3.1% 7
2023
Q3 		$7.84M Buy
112,308
+16,613
+17% +$1.18M 3.02% 13
2023
Q2 		$6.62M Sell
95,695
-652
-0.7% -$46.4K 2.34% 26
2023
Q1 		$7.16M Buy
96,347
+712
+0.7% +$59.7K 2.71% 21
2022
Q4 		$8.91M Sell
95,635
-707
-0.7% -$68.2K 3.5% 5
2022
Q3 		$9.19M Sell
96,342
-968
-1% -$95.8K 3.81% 1
2022
Q2 		$9.02M Sell
97,310
-173
-0.2% -$16.9K 3.28% 7
2022
Q1 		$9.87M Sell
97,483
-11,615
-11% -$1.22M 3.13% 6
2021
Q4 		$11.3M Sell
109,098
-3,743
-3% -$346K 3.87% 2
2021
Q3 		$9.58M Buy
112,841
+3,912
+4% +$328K 3.36% 8
2021
Q2 		$9.09M Buy
108,929
+710
+0.7% +$58.1K 3.46% 10
2021
Q1 		$8.14M Buy
108,219
+13,954
+15% +$1.02M 3.57% 7
2020
Q4 		$6.44M Buy
94,265
+13,169
+16% +$857K 3.48% 8
2020
Q3 		$4.74M Buy
81,096
+10,158
+14% +$632K 3.33% 13
2020
Q2 		$4.61M Buy
70,938
+18
+0% +$1.13K 3.36% 12
2020
Q1 		$4.21M Sell
70,920
-286
-0.4% -$19.1K 4.03% 7
2019
Q4 		$5.29M Buy
+71,206
New +$5M 3.75% 6

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Mark Hillman's CVS Position: Q2 2026 in Review

Mark Hillman reduced its CVS Health (CVS) stake by 18% in Q2 2026, selling an estimated $1.07M and leaving 55,475 shares worth $5.74M. The position accounts for 4.15% of the portfolio, ranked #1.

Mark Hillman first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $11.3M in Q4 2021. 2,059 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Mark Hillman held 55,475 shares of CVS Health worth $5.74M as of Q2 2026.
  • Mark Hillman sold 11,987 CVS Health shares in Q2 2026, an estimated $1.07M.
  • CVS Health made up 4.15% of Mark Hillman's portfolio in Q2 2026, its #1 holding.
  • Mark Hillman first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • Mark Hillman's CVS Health position peaked at $11.3M in Q4 2021.
  • 2,059 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Hillman Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.